Phase I Study of GC1008 in Patients With Primary Myelofibrosis (PMF), Post-polycythemia Vera/Essential Thrombocythemia Related Myelofibrosis (Post-PV/ET MF).
Phase of Trial: Phase I
Latest Information Update: 07 Dec 2014
At a glance
- Drugs Fresolimumab (Primary)
- Indications Essential thrombocythaemia; Myelofibrosis; Polycythaemia vera
- Focus Adverse reactions
- 07 Jun 2017 Biomarkers information updated
- 01 Jan 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 08 Mar 2012 Actual patient number (3) added as reported by ClinicalTrials.gov.